VEA
IMVT icon

Virtus ETF Advisers’s Immunovant IMVT Stock Holding History

Virtus ETF Advisers’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-2,577
Closed -$63.8K – 599
2024
Q4 		$63.8K Sell
2,577
-885
-26% -$25.1K 0.03% 429
2024
Q3 		$98.7K Buy
3,462
+59
+2% +$1.74K 0.05% 379
2024
Q2 		$89.8K Buy
3,403
+1,372
+68% +$39K 0.04% 358
2024
Q1 		$65.6K Sell
2,031
-143
-7% -$5.22K 0.03% 412
2023
Q4 		$91.6K Sell
2,174
-2,473
-53% -$91K 0.06% 400
2023
Q3 		$178K Sell
4,647
-460
-9% -$10.4K 0.11% 283
2023
Q2 		$96.9K Sell
5,107
-1,594
-24% -$29.7K 0.06% 399
2023
Q1 		$104K Sell
6,701
-2,575
-28% -$44.7K 0.06% 334
2022
Q4 		$165K Sell
9,276
-21,091
-69% -$266K 0.09% 327
2022
Q3 		$169K Buy
30,367
+221
+0.7% +$1.08K 0.07% 335
2022
Q2 		$118K Buy
30,146
+8,984
+42% +$38.8K 0.04% 389
2022
Q1 		$117K Sell
21,162
-1,273
-6% -$7.93K 0.05% 272
2021
Q4 		$191K Buy
22,435
+2,641
+13% +$21.8K 0.07% 226
2021
Q3 		$172K Sell
19,794
-1,033
-5% -$9.32K 0.08% 305
2021
Q2 		$220K Buy
20,827
+14,684
+239% +$205K 0.09% 275
2021
Q1 		$99K Buy
6,143
+115
+2% +$3.03K 0.04% 351
2020
Q4 		$278K Buy
+6,028
New +$279K 0.12% 250

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
AGM
Alpine Global Management New York $668M AUM 20.22% 1-Year Est. Return

Virtus ETF Advisers's IMVT Position: Q1 2025 in Review

Virtus ETF Advisers sold out of Immunovant (IMVT) in Q1 2025, closing a stake of 2,577 shares — an estimated $63.8K sold.

Virtus ETF Advisers first reported a position in IMVT in Q4 2020 and held it in 17 quarters. The position peaked at $278K in Q4 2020. 193 funds tracked by Wall St. Rank hold IMVT as of Q1 2025.

  • Virtus ETF Advisers reported no remaining Immunovant position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 2,577 Immunovant shares in Q1 2025, an estimated $63.8K.
  • Virtus ETF Advisers first reported a position in Immunovant in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's Immunovant position peaked at $278K in Q4 2020.
  • 193 funds tracked by Wall St. Rank held Immunovant as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.